"SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit" presented by Amy Li

Sdílet
Vložit
  • čas přidán 8. 07. 2024
  • medschool.cuanschutz.edu/medi... | University of Colorado | Department of Medicine | Division of Renal Diseases and Hypertension's February 9, 2022 Grand Rounds-SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit presented by Amy Li, first year renal fellow-research track.

Komentáře •